trial · primary record
PF-07220060
Liposarcoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 430 |
| Primary completion | 2029-10-07 |
| Primary endpoint | Number of participants with dose limiting toxicities in the Dose Escalation or De-escalation Portion |
| Registry ID | NCT04557449 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:02.063Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04557449
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.